HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Moniliformin

HCID 178927506
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
39284-13-4
Standard SMILES
O=c1cc(O)c1=O
InChIKey
KGPQKNJSZNXOPV-UHFFFAOYSA-N
Molecular formula
C4H2O3
Average molar mass
98.06 g/mol

Overview

Moniliformin is an enol and an enone.

Names & identifiers

Preferred name
Moniliformin
IUPAC
3-hydroxycyclobut-3-ene-1,2-dione
English name
2-hydroxycyclobut-2-ene-1,4-dione
Molecular formula
C4H2O3
Molecular weight
0

Names & synonyms

Moniliformin31876-38-73-hydroxycyclobut-3-ene-1,2-dioneSemisquaric acid3-Cyclobutene-1,2-dione, 3-hydroxy-1-Hydroxycyclobut-1-ene-3,4-dioneHydroxycyclobutenedione3-Hydroxy-3-cyclobutene-1,2-dione3-Hydroxy-3-cyclobutenedioneG5JMQ8SDF81-Hydroxy-cyclobut-1-ene-3,4-dioneDTXSID10185731
Show more names
Ccris 4943Brn 19253392-hydroxycyclobut-2-ene-1,4-dione
RefChem:159498DTXCID50108222636-113-2981-476-51-hydroxycyclobutene-3,4-dioneNSC2928961345994-72-039284-13-4

Database identifiers

CAS
39284-13-4
ChEMBL
CHEMBL1977616
ChEBI
CHEBI:222613
UNII
G5JMQ8SDF8
EC Number
636-113-2、981-476-5
Nikkaji
J20.107C

Properties

Computed structural propertiesFilling in

XLogP
-0.6
Topological polar surface area
54.4 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
3
Rotatable bonds
0
Heavy atoms
7
Formal charge
0
Complexity
166

Physicochemical properties

FDA UNII
5 JMQ8SDF8 · G5JMQ8SDF8

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 6 items

Danger

H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]

P264, P270, P301+P316, P321, P330, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 41 reports by companies from 2 notifications to the ECHA C&L Inventory.

Danger

H300 (100%): Fatal if swallowed [Danger Acute toxicity, oral]

Hazard information

Regulatory InformationRegulation (EC) No 178/2002 (amended)
Hazard Classes and Categories · 2 items

Acute Tox. 3 (100%)

Acute Tox. 2 (100%)

Toxicology

TreatmentKashin-Beck disease cannot be cured but can be treated with physical therapy and corrective surgery. Natamycin ophthalmic suspension is the drug of choice for filamentous fungal infections such as mycotic keratitis. (L1964, L1828)
Health Effects · 1 item

Moniliformin is believed to be a cause of Kashin-Beck disease, which causes joint destruction and deformity. It may also have immunosuppressive properties and can cause fungal infections such as mycotic keratitis. (A3021, A3075, A3076, L1970)

Exposure RoutesOral, dermal, inhalation, and parenteral (contaminated drugs). (A3101)
Toxicity Summary · 1 item

Moniliformin reversibly inhibits the enzymes pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase by competing for the binding site of pyruvate. This interferes with the tricarboxylic acid cycle by preventing the necessary incorporation of pyruvate and oxidation of the alpha-ketoglutarate intermediate. Moniliformin has also been shown to interfere with carbohydrate metabolism by inhibiting transketolase and aldose reductase. Moniliformin causes the necrosis of human chondrocytes in cartilage. It does so by increasing the expression of matrix catabolic enzymes, such as MMP-1 and MMP-13, and decreasing the syntheses of extracellular matrix components such as aggrecan and type II collage. This accelerates the catabolism of the extracellular matrix in articular cartilages, inducing a loss of cartilage function and eventually leading to cartilage degradation. Moniliformin is also known to cause DNA damage, inducing chromatid breaks, chromosome breaks, and chromatid exchanges. (A3075, A3076, A3077)

Chemistry & industry

Uses & manufacturing

UsesMoniliformin is a mycotoxin produced by a number of fungi of the Fusarium species. It can by found in contaminated cereal crops. (L1969, A3075)

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Signs and Symptoms · 1 item

The main symptoms of acute moniliformin toxication in animals are muscular weakness, respiratory stress, myocardial degeneration, as well as some histopathological changes in organs such as the kidneys, the lungs and the pancreas, followed by coma and death. Kashin-Beck disease is characterized by joint pain, with restriction of movement and joint enlargement. (A3077)

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).